Japan's Shionogi to raise stake in UK HIV drugmaker ViiV with $2.1bn investment
MLex Summary: Japan’s Shionogi has agreed to increase its stake in UK-based HIV drugmaker ViiV Healthcare, investing $2.1 billion to raise its holding from 10 percent to 21.7 percent. The Osaka-based...To view the full article, register now.
Already a subscriber? Click here to view full article